We are live on ! Find out more

745 hedge funds and large institutions have $37B invested in Aptiv in 2021 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 304 increasing their positions, 233 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more first-time investments, than exits

New positions opened: 88 | Existing positions closed: 52

30% more repeat investments, than reductions

Existing positions increased: 304 | Existing positions reduced: 233

4% more funds holding

Funds holding: 717745 (+28)

0.52% more ownership

Funds ownership: 91.3%91.82% (+0.52%)

5% less capital invested

Capital invested by funds: $38.9B → $37B (-$1.91B)

19% less call options, than puts

Call options by funds: $142M | Put options by funds: $174M

23% less funds holding in top 10

Funds holding in top 10: 1310 (-3)

Holders
745
Holders Change
+28
Holders Change %
+3.91%
% of All Funds
13.01%
Holding in Top 10
10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-23.08%
% of All Funds
0.17%
New
88
Increased
304
Reduced
233
Closed
52
Calls
$142M
Puts
$174M
Net Calls
-$32.3M
Net Calls Change
+$21.8M

APTV Hedge Fund Activity: Q3 2021 in Review

745 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Aptiv (APTV) for Q3 2021, worth a combined $37B — down 4.9% from $38.9B a quarter earlier.

Buyers outnumbered sellers: 88 funds opened new APTV positions and 52 closed out — a net gain of 36 holders — while 304 added to existing stakes and 233 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $219M. The largest seller was T. Rowe Price Associates, cutting an estimated $948M.

  • 745 institutional investors held Aptiv (APTV) as of Q3 2021, up from 717 in Q2 2021.
  • Funds reported $37B of Aptiv stock for Q3 2021, down 4.9% quarter-over-quarter.
  • 88 funds opened new Aptiv positions in Q3 2021 and 52 closed out, a net change of +36 holders.
  • The largest Aptiv buyer in Q3 2021 was Capital Research Global Investors, an estimated $219M added.
  • The largest Aptiv seller in Q3 2021 was T. Rowe Price Associates, an estimated $948M sold.

Based on aggregated 13F filings for Q3 2021.